FLASCO / e-Learning

Free CE online now about MDS

Amanda Bridges
June 24, 2020
e-Learning
No Comments

Target Audience Nurse practitioners, nurses and oncology social workers involved in the care of patients with myelodysplastic syndromes (MDS) Course Content Level for Social Workers: Intermediate and Advanced Description This webinar will provide a basic overview of myelodysplastic syndromes (MDS): focusing on strategies for diagnosis and patient management. Risk assessment, treatment options, the role of various members of the…

Safely reopening amid COVID-19: Vendor/Rep Protocol Updates

Amanda Bridges
June 1, 2020
e-Learning
No Comments

RxVantage is offering an on-demand webinar on safely reopening amid COVID-19. Here is the link to the new on-demand webinar. This webinar covers policy recommendations for dealing with your rep/vendor community as well as recommendations for updating protocols to fit social distancing guidelines.

Seattle Genetics Hodgkin’s Lymphoma Virtual Product Theater Program Invite 6/24/20

Amanda Bridges
May 11, 2020
e-Learning
No Comments

Join our Virtual Speaker Event to hear from EVENTYair Levy, MD, of Baylor Scott & White Health in Dallas, TX discuss 2020 ADCETRIS® (brentuximab vedotin)

Seattle Genetics Hodgkin’s Lymphoma Virtual Product Theater Program Invite 6/9/20

Amanda Bridges
May 11, 2020
e-Learning
No Comments

Join our Virtual Speaker Event to hear from Andrew Evens, DO, MSc, of Rutgers Cancer Institute of New Jersey, New Brunswick, NJ discuss 2020 ADCETRIS® (brentuximab vedotin)

Seattle Genetics Hodgkin’s Lymphoma Virtual Product Theater Program Invite 5/20/20

Amanda Bridges
May 11, 2020
e-Learning
No Comments

Join our Virtual Speaker Event to hear from Yair Levy, MD, of Baylor Scott & White Health in Dallas, TX discuss 2020 ADCETRIS® (brentuximab vedotin)

Seattle Genetics Hodgkin’s Lymphoma Virtual Product Theater Program Invite 5/14/20

Amanda Bridges
May 11, 2020
e-Learning
No Comments

Join our Virtual Speaker Event to hear from Andrew Evens, DO, MSc, of Rutgers Cancer Institute of New Jersey, New Brunswick, NJ discuss 2020 ADCETRIS® (brentuximab vedotin)

LLS Podcast Series for Professionals

FLASCO
April 28, 2020
e-Learning
No Comments

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts…

Pfizer Educational Videos

Amanda Bridges
September 13, 2019
e-Learning
No Comments

Watch educational videos on biosimilars. Pfizer is proud to offer an array of videos for healthcare professionals looking for more information about biosimilars.

Radon Education

Amanda Bridges
September 10, 2019
e-Learning
No Comments

Radon, is the number one leading cause of lung cancer among non-smokers in the U.S. Radon is a colorless, odorless, and tasteless gas that you would have no way of knowing you were being exposed to.

Biosimilar Education

FLASCO
June 3, 2019
e-Learning
No Comments

To help foster a better understanding of biosimilars, Teva has created a resource center to house the latest information from their experts. Vist TevaBiosimilars.com to learn more

Educational Opportunity in Oncofertility

Katrina Williams
May 3, 2019
e-Learning
No Comments

Enriching Communication Skills for Health Professionals in Oncofertility (ECHO) is a free web-based training program focusing on building communication skills. Training Topics include: Risk of infertility Fertility preservation Sexual functioning Body image Ethical, social, and cultural considerations Interested learners should submit their application on our website at: https://echo.rhoinstitute.org/2020-echo-application/. Deadline to apply is November 22nd, 2019….

Merck and FLASCO Present Universal MSI/MMR Testing in Colorectal Cancer

Amanda Bridges
April 25, 2019
e-Learning
No Comments

FLASCO, in partnership with Merck is pleased to present the educational video: Universal MSI/MMR Testing in Colorectal Cancer featuring FLASCO Immediate Past President, Rick McDonough, MD and FLASCO Board Member Liaison, Farah Khalil, MD, FCAP.

CAR T-CELL THERAPY: RECENT ADVANCES AND FUTURE CONSIDERATIONS

Amanda Bridges
November 18, 2018
e-Learning
No Comments

RECORDED WEBINAR Learn about the ways in which CAR T-cell therapy treats blood cancer, what CAR T therapy means for the future of cancer treatment, and the current patient access environment and other key considerations. PRESENTERS Frederick Locke, MD, Moffitt Cancer Center Krishna V. Komanduri, MD, Sylvester Comprehensive Cancer Center Brian Koffman, MD, CLL Society,…

NAVIFY – Decision Support Portfolio

Amanda Bridges
October 8, 2018
e-Learning
No Comments

To make the best treatment decision, we have to apply the latest medical knowledge to a patient’s medical history, personal preferences and circumstances, test results, images, reports and other information. NAVIFY elevates our efficiency and confidence by aggregating these resources. Website: https://www.navify.com/

The First FDA-approved Anti-PDL1 Cancer Immunotherapy in Locally Advanced or Metastatic Urothelial Carcinoma

Amanda Bridges
October 13, 2017
e-Learning
No Comments

Watch Here: www.tecentriq-ondemand.com

FLASCO Administrator Network Patient Support Resources Webinar

FLASCO
January 12, 2017
Administrative
No Comments

On January 12, 2017, the FLASCO Administrator Network hosted its first webinar. The topic was Patient Support Resources, and it featured experts from community oncology and hospital settings, who shared their tips, helpful hints, and tools of the trade regarding assistance programs and resources available for cancer patients. Congratulations to Maggie Wiegandt, MBA and Gail…

Genentech’s TECENTRIQ Upcoming Webinars

Amanda Bridges
September 15, 2016
e-Learning
No Comments

On behalf of Genentech, you are invited to attend one of three webcasts across two days that span lunch times across 3 time zones: Introducing TECENTRIQ: The First and Only FDA-Approved Anti-PDL1 Immunotherapy for Previously Treated Locally Advanced Metastatic Urothelial Carcinoma September 28, 2016 Fairooz Kabbinavar, MD – UCLA, Los Angeles, CA 3:00pm ET, 2:00pm…

ASCO Annual Meeting Collective Wisdom

Amanda Bridges
September 12, 2016
e-Learning
No Comments

Novartis Oncology is pleased to invite you to virtually attend sessions from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting. To access the virtual platform please register at www.asco2016.com/FLASCO to begin viewing the recorded video sessions in the single track of your choice and learn about the practice-changing advances in oncology presented at…

Myriad myPlan Lung Cancer

Amanda Bridges
July 28, 2016
e-Learning
No Comments

Myriad’s myPlan® Lung Cancer is a new gene expression signature based on 31 cell cycle progression (CCP) genes —the genes that regulate cell division. myPlan Lung Cancer measures the expression levels of specific genes in combination with pathological stage to predict the 5-year risk of lung cancer death in patients with surgically resected early-stage NSCLC. …

Pfizer Biosimilars: Landscape of Biosimilars

Amanda Bridges
May 24, 2016
e-Learning
No Comments

XTANDI

FLASCO
August 3, 2015
e-Learning
No Comments

Astellas Pharmaceuticals Start XTANDI at disease progression to metastatic CRPC for your patients on GnRH therapy*1. Click here to create your signature program.

Physician Resources NEW T-cell Lymphoma Resource Center Now Available Through QuantiaMD

Amanda Bridges
July 8, 2015
e-Learning
No Comments

This educational resource is provided by Celgene and designed to provide an understanding of the classification, diagnosis of subtypes, and disease management of peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL). Physicians can choose to “follow” the resource center and receive alerts when new information is added. To visit the T-cell Lymphoma Resource Center,…